Generic and Innovative Drug Market in CE Countries 2011 - Comparative Analysis, Reimbursement Policies and Development Forecasts for 2011-2013

Date: February 22, 2011
Price:
US$ 3,410.00
Publisher: PMR
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: G8C9F9208A3EN
Leaflet:

Download PDF Leaflet

Generic and Innovative Drug Market in CE Countries 2011 - Comparative Analysis, Reimbursement Policies and Development Forecasts for 2011-2013
Single user licence: - US$ 3,410.00
5-user licence: - US$ 5,115.00
Corporate licence: - US$ 6,815.00
Global licence: - US$ 8,520.00


Generic and innovative drug market in CE countries 2011 is a unique new report that provides a detailed illustration of the current market conditions in Central Europe, both as one cohesive region and in the individual marketplaces of:

Poland, Romania, Slovakia, the Czech Republic, Hungary and Bulgaria.

In addition to the latest analysis of key effects of recent economic difficulties in these markets, this timely document provides comparative analysis, news on reimbursement policies and the development forecasts for 2011-2013 needed for success in this quickly changing industry.

The expert analysts at PMR Publications have closely examined the issues that affect market conditions and require skillful navigation within today’s CE generic and innovative drug market:
  • prices
  • reimbursement policies
  • insurers, exclusivity of data regulations
  • formula patent time periods
  • expiration dates
  • counterfeit medicines.

They have carefully compiled their research, analysis and projections to create a single concise and cost-effective document that saves readers time and money by offering the widest scope of necessary coverage without sacrificing any of the required detail.

The report presents a sharply-focused view of the future by predicting changes in market size and share for the coming two years, as well as in-depth treatment of current and future reimbursement lists and processes and their impact on the market. It examines VAT rates, and outlines expected changes in data exclusivity periods allotted to innovative medicine companies.

Readers will gain an insightful understanding of the behaviour and reasoning of market participants through detailed description of:
  • the preferences of the consumer, medical patient and prescribing physician concerning generics and innovative drugs
  • company profiles that spotlight the activities and achievements of the largest developers, manufacturers and distributors of the many products that are classified in this specific portion of the region’s pharmaceutical market.
I. REPORT METHODOLOGY

II. EXECUTIVE SUMMARY

III. CHARACTERISTICS OF GENERIC AND INNOVATIVE DRUG MARKETS IN CENTRAL EUROPEAN COUNTRIES

Comparative analysis
Prices of generic and innovative drugs
Market value between 2008 and 2013
Average CAGR for generic and innovative drug markets in CE countries 2011-2013
Market share of generic and innovative medicines
Main trends and events on generic and innovative drug market
Market size
Share of pharmaceutical market
Market forecasts for 2011-2013

IV.BEST-SELLING DRUGS IN CENTRAL EUROPE

Best-selling drugs
Drug patent expiry and data exclusivity periods
Comparative analysis of drug patent expiry and data exclusivity periods in CE

V.COUNTERFEIT PRODUCTS

VI.REIMBURSEMENT AND PRICING POLICIES IN CENTRAL EUROPE

Pricing policies
VAT rate
Non-reimbursed drugs on pharmacy market
Reimbursed drugs on pharmacy market
Drugs on hospital market
Reimbursement policies
Reimbursement system
Reimbursement process
Reimbursement spending
Reimbursement reform
Latest changes to reimbursement lists
Expected changes to reimbursement lists

VII.KEY MANUFACTURERS

Profiles of selected leading generic drug manufacturers in CE
Profiles of selected leading innovative drug manufacturers in CE
Key players in selected CE countries
Skip to top


Ask Your Question

Generic and Innovative Drug Market in CE Countries 2011 - Comparative Analysis, Reimbursement Policies and Development Forecasts for 2011-2013
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: